Tirzepatide changes eating behavior and diet quality of life in type 2 diabetes patients within 3 months
In 60 T2DM outpatients, 3 months of tirzepatide produced significant changes in eating behavior alongside weight loss and HbA1c improvement, with diet-related quality of life impacts assessed.
Quick Facts
What This Study Found
Tirzepatide: significant changes in eating behavior at 3 months. Weight loss and HbA1c improvement. Diet-related QoL changes assessed. 60 T2DM outpatients.
Key Numbers
How They Did This
Observational study of 60 T2DM outpatients on tirzepatide for 3 months. Eating behavior questionnaires. Body weight. HbA1c. Diet-related QoL assessment.
Why This Research Matters
GLP-1/GIP drugs fundamentally change how people relate to food. Understanding these behavioral changes helps clinicians provide holistic support during treatment.
The Bigger Picture
The behavioral aspects of GLP-1 drugs—how they change food preferences, portion sizes, and eating patterns—are as important as their metabolic effects for long-term success.
What This Study Doesn't Tell Us
Small study (60). Short follow-up (3 months). Single center. No control group. Diet QoL tools may not capture all relevant changes.
Questions This Raises
- ?Do eating behavior changes persist after stopping tirzepatide?
- ?Which specific eating behaviors change most?
- ?Does diet QoL improve or worsen overall?
Trust & Context
- Key Stat:
- Eating behavior transformed Tirzepatide significantly changed eating behavior within 3 months—understanding these changes helps clinicians support the psychological aspects of GLP-1 treatment
- Evidence Grade:
- Small observational study. Good for behavioral insights but limited generalizability.
- Study Age:
- Published in 2025.
- Original Title:
- Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.
- Published In:
- Diabetology international, 16(4), 648-660 (2025)
- Authors:
- Toga-Sato, Shiori, Tosaki, Takahiro, Hodai, Yuichi, Kondo, Masaki, Miura-Yura, Emiri, Kato, Makoto, Morishita, Yoshiaki, Tsunekawa, Shin, Himeno, Tatsuhito, Kato, Yoshiro, Nakamura, Jiro, Kamiya, Hideki
- Database ID:
- RPEP-13814
Evidence Hierarchy
Frequently Asked Questions
How does tirzepatide change eating behavior?
This study found significant changes in eating patterns within 3 months of starting tirzepatide. Patients reported altered food preferences and eating behaviors alongside weight loss. Understanding these changes helps patients and their healthcare team adapt to the drug's effects on appetite and food enjoyment.
Will food still be enjoyable on tirzepatide?
Diet-related quality of life changes are part of the GLP-1 drug experience. This study formally assessed these changes, recognizing that while weight loss is the goal, how patients feel about food matters too. Working with a dietitian can help maintain food enjoyment while adapting to new appetite levels.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-13814APA
Toga-Sato, Shiori; Tosaki, Takahiro; Hodai, Yuichi; Kondo, Masaki; Miura-Yura, Emiri; Kato, Makoto; Morishita, Yoshiaki; Tsunekawa, Shin; Himeno, Tatsuhito; Kato, Yoshiro; Nakamura, Jiro; Kamiya, Hideki. (2025). Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.. Diabetology international, 16(4), 648-660. https://doi.org/10.1007/s13340-025-00829-7
MLA
Toga-Sato, Shiori, et al. "Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.." Diabetology international, 2025. https://doi.org/10.1007/s13340-025-00829-7
RethinkPeptides
RethinkPeptides Research Database. "Changes in eating behavior and diet-related quality of life ..." RPEP-13814. Retrieved from https://rethinkpeptides.com/research/toga-sato-2025-changes-in-eating-behavior
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.